earnings
CV
NASDAQ · CVKD
Cadrenal Therapeutics, Inc. Common Stock
Healthcare · Biotechnology
$1.71
Down-$0.04 (-2.29%)
Updated Aug 19, 2026, 9:23 AM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 22.83M
- P/E ratio
- -1.56
- Dividend yield
- 0.00%
- 52-week range
- $1.71 – $8.35
- Volume
- 59.49K
- Avg. volume
- 27.14K
Price performance
CVKD price history
1M range · 21 trading sessions · Daily adjusted prices
CVKD closed at $1.71 after 21 trading sessions, down 21.20% for the selected period.
- Last close
- $1.71
- Period change
- -21.20%
- Period low
- $1.71
- Period high
- $2.17
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 18, 2026 | $1.76 | $1.82 | $1.64 | $1.71 | 59.49K |
| Aug 17, 2026 | $1.88 | $1.88 | $1.71 | $1.76 | 37.2K |
| Aug 14, 2026 | $1.88 | $1.9139 | $1.79 | $1.87 | 27.91K |
| Aug 13, 2026 | $1.85 | $1.9686 | $1.76 | $1.86 | 35.86K |
| Aug 12, 2026 | $1.9448 | $1.98 | $1.77 | $1.84 | 63.74K |
| Aug 11, 2026 | $1.975 | $2.12 | $1.92 | $1.94 | 46.33K |
| Aug 10, 2026 | $1.96 | $2.0126 | $1.91 | $1.94 | 19.98K |
| Aug 7, 2026 | $1.90 | $2.05 | $1.87 | $1.95 | 30.08K |
| Aug 6, 2026 | $1.98 | $1.9908 | $1.87 | $1.87 | 25.72K |
| Aug 5, 2026 | $2.07 | $2.10 | $1.90 | $1.96 | 33.04K |
| Aug 4, 2026 | $1.96 | $2.17 | $1.96 | $2.03 | 40.67K |
| Aug 3, 2026 | $1.97 | $2.16 | $1.90 | $1.96 | 40.92K |
| Jul 31, 2026 | $2.08 | $2.11 | $1.97 | $2.01 | 14.94K |
| Jul 30, 2026 | $2.01 | $2.09 | $1.9614 | $2.09 | 17.77K |
| Jul 29, 2026 | $1.99 | $2.05 | $1.96 | $1.97 | 13.77K |
| Jul 28, 2026 | $2.06 | $2.095 | $1.98 | $2.01 | 32.73K |
| Jul 27, 2026 | $2.14 | $2.14 | $1.95 | $2.06 | 71.12K |
| Jul 24, 2026 | $2.05 | $2.16 | $1.92 | $2.04 | 80.26K |
| Jul 23, 2026 | $2.05 | $2.125 | $1.86 | $2.03 | 59.7K |
| Jul 22, 2026 | $2.17 | $2.2417 | $2.05 | $2.10 | 39.37K |
| Jul 21, 2026 | $2.14 | $2.3852 | $2.10 | $2.17 | 168.42K |
Latest CVKD news
The latest Smart Investors Daily articles mentioning CVKD.
Stock researchResearch & News · Analysis
Loading stock research…

